Michael Andrew Chambers - 06 Mar 2023 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Director
Signature: /s/ Ryan Brown, as Attorney-in-Fact for Michael Chambers
Issuer symbol: SRPT
Transactions as of: 06 Mar 2023
Transactions value $: $0
Form type: 4
Filing time: 08 Mar 2023, 19:00:46 UTC
Previous filing: 15 Sep 2022
Next filing: 11 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Award	$0	+1.52K	+31.03%	$0.00	6.43K	06 Mar 2023	Direct	F1
holding	SRPT	Common Stock						178K	06 Mar 2023	By Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Option (right to buy)	Award	$0	+3.26K		$0.00	3.26K	06 Mar 2023	Common Stock	3.26K	$155.99	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024.